Attitudes to Mistakes. Changing prescription and protocol philosophy.
As an older patient, I am 89, I have one thing many others do not have, experience. As an engineer with much experience in manufacturing industry I have seen great recent changes in manufacturing sociology. Now, even top management comes to listen to “the Gemba” (the shop floor) and what could be regarded as mistakes are seen as opportunities to improve... more »

We in Wisconsin have developed a robust training program for mixed MD and PhD postdocs in a clinical dept and yet their future in research is blocked by few faculty positions, poor funding and over complicated NIH applications. One of the simplest grants is the R03 and we have already had graduates with only a few years postdoc experience succeed in gaining R03 funding. The R03 is a very simple very flexible mechanism.... more »

Why don’t we have a program that is easy to follow in maintaining at an early age that extends all the way to Senior Citizenship? Culturally diverse staff can improve everyones chances of getting needed care that is multi-cultural.

Why can’t all training grants (T, K, etc) be opened out to all people working in US institutions, regardless of citizenship or green-card?

Why can’t we establish mechanisms for US junior investigators and mentors interested in global NHLBI areas?

What are the best strategies to develop a highly competent diverse Implementation Science research workforce to address health inequities?

What are the institutional factors, including structure and culture of care, that characterize systems performance? Which of these factors are potentially modifiable and/or scalable?

Extend trainee funding support to non‐US citizens for those that commit to serving in underserved medical areas in the U.S. for at least five years.

How do we redefine success to include scientific careers other than research (e.g., careers in teaching, industry, government) and provide opportunities for exposure to alternative careers?

Maintaining the pipeline of clinician scientists via early and mid-career awards. Promote the development of collaborative teams.

How can we provide better support for junior investigators who are transitioning from K Award to R Award funding?

Basic scientists and clinicians have different training and bring different perspectives to lung disease research. Additionally, mechanisms that facilitate interactions of scientists from different fields may improve communication and facilitate novel ideas for lung disease research. I would like to see a funding mechanism that encouraged such partnerships in addressing fundamental disease questions and/or treatments.... more »

As seen by ~ 40% steady decline in number of K-08 grant applicants over 2005-2014 period, early career physician scientists who can do both basic-translation research and take care of patients are dwindling. Lack of institutional support, lack of ACGME support, increasing demands of clinical training, increasing compliance requirement, and disadvantaged position (i.e., significantly less preparation time and continued... more »

We need to spread R01 funding around more to ensure that the best science has funding adequate to move forward. To do this I believe changing how we think about R01 funding and expenditures can be used to put the NIH funds to better use. Too often successful researchers have the majority of their salaries on R01s and the institutions have little skin in the game. PI salaries can be a large part of the escalating budget... more »

The main therapeutic challenges that remain to be addressed in the field of cardiac arrhythmias generally require the participation of scientific expertises as diverse as physiology, medicine, engineering, chemistry, nanotechnology, material science and others. Today, there is little incentive to assemble such cross-expertise teams. Novel funding mechanisms could reward the time and effort invested in forming cross-expertise... more »

Patients with vascular anomalies frequently see many physicians and undergo extraneous tests with incorrect diagnoses. A major reason for this is due to the fact that medical training does not include Vascular Anomalies in the syllabus. Thus, many specialties erroneously use the term "hemangioma" for any vascular diagnosis. Over the past 2 decades, there have been major breakthroughs in basic and genetic research, as... more »